ENDONOVO THERAPEUTICS, INC. (ENDV) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US29272H3003
ENDONOVO THERAPEUTICS, INC. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 10,043.00 USD | – |
| Gross profit | -615,198.00 USD | – |
| Operating income | -1.56 m USD | -945,766.00 USD |
| Net income | -2.80 m USD | -2.18 m USD |
Full history since 2009, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About ENDONOVO THERAPEUTICS, INC.
Endonovo Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and distribution of non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of cardio chronic kidney disease, liver disease non-alcoholic steatohepatitis (NASH), cardiovascular, and peripheral artery disease (PAD) and ischemic stroke. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.
More stocks
- Glucotrack, Inc. (GCTK)
- CUMULUS MEDIA INC (CMLSQ)
- GIVBUX, INC. (GBUX)
- NetBrands Corp. (NBND)
- Sadot Group Inc. (SDOT)
- Nature's Miracle Holding Inc. (NMHI)
- Trans American Aquaculture, Inc (GRPS)
- SOBR Safe, Inc. (SOBR)
- Aptevo Therapeutics Inc. (APVO)
- 1847 Holdings LLC (LBRA)
- Mobile Global Esports, Inc. (MGAM)
- TRAFALGAR INTERNATIONAL, INC. (GCAN)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.